Jubilant Cadista Pantoprazole Tablets Recall: Dark Spots on Edges
Jubilant Cadista recalls 40mg Pantoprazole tablets with dark discoloration on edges. Stop using if you see brown spots. No remedy provided in official notice.
Lower-risk recall
Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.
Contact the company
What happened, in plain English
Jubilant Cadista is recalling 40mg Pantoprazole Sodium Delayed-Release Tablets that may have dark brown spots on the edges. This discoloration could indicate a quality issue that might affect the medication's safety or effectiveness. If you have these tablets and notice discoloration, you should stop using them. Read more at govinfonow.com/recall/39545-jubilant-cadista-pantoprazole-tablets-recall-dark-spots-on-edges.
Source Summary by GovInfoNow · govinfonow.com/recall/39545-jubilant-cadista-pantoprazole-tablets-recall-dark-spots-on-edges · Updated October 6, 2026 · FDA enforcement record: FDA #D-0011-2019
Cite this page
“Jubilant Cadista Pantoprazole Tablets Recall: Dark Spots on Edges.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39545-jubilant-cadista-pantoprazole-tablets-recall-dark-spots-on-edges. Based on FDA recall #D-0011-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0011-2019%22&limit=1).
Why it’s dangerous
Dark discoloration on the edges of the tablets may indicate a quality issue that could affect the medication's safety or effectiveness. However, the recall does not specify that this discoloration causes harm in normal use.
Who’s affected
People who have the 40mg Pantoprazole tablets with dark brown spots on the edges. Those taking this medication for acid reflux or ulcers are most at risk if the tablets are unsafe.
How to tell if you have this one
Check for dark brown spots on the edges of the 40mg Pantoprazole tablets. The affected lots are listed in the product description with specific expiration dates and manufacturing codes.
- Brand
Jubilant Cadista- Category
Drug
What to do — step by step
Check for discoloration
Look for dark brown spots on the edges of the tablets. If present, stop using the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Product was distributed Nationwide in the USA and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0011-2019 (October 2, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0011-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.